Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity—A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial

INTRODUCTION: Chronic kidney disease (CKD) is associated with high cardiovascular morbidity and mortality. Recent evidence suggests that increases in both serum and intracellular magnesium (Mg) can slow or even prevent the development of vascular calcification seen in CKD. Serum calcification propen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int Rep
Main Authors: Bressendorff, Iain, Hansen, Ditte, Schou, Morten, Silver, Burton, Pasch, Andreas, Bouchelouche, Pierre, Pedersen, Lise, Rasmussen, Lars Melholt, Brandi, Lisbet
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2016
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5678662/
https://ncbi.nlm.nih.gov/pubmed/29142966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2016.12.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados